{
 "note": "Dated snapshots of GLPOneReview's compounded price summary. Older snapshots are superseded, not corrected in place.",
 "snapshots": [
  {
   "date": "2026-07-06",
   "source": "third-party price list (RangeYourself, starting prices, human-verified July 1-3, 2026), not first-party reads",
   "semaglutide_range": [
    79,
    289
   ],
   "tirzepatide_range": [
    129,
    349
   ],
   "nexlife": {
    "semaglutide": 119,
    "tirzepatide": 139
   },
   "status": "superseded"
  },
  {
   "date": "2026-11-08",
   "source": "first-party reads 2026-10-15; NexLife 2026-11-06",
   "basis": "lowest all-in monthly figure per compounded program, membership included (annual fee / 12); standard-dose injectable; first-party reads 2026-10-15 except NexLife 2026-11-06",
   "tirzepatide": {
    "programs": 24,
    "low": 86,
    "high": 299,
    "median": 144
   },
   "semaglutide": {
    "programs": 22,
    "low": 49,
    "high": 279,
    "median": 99
   },
   "nexlife": {
    "tirzepatide": [
     129,
     125,
     119,
     115
    ],
    "semaglutide": [
     109,
     105,
     99,
     95
    ]
   },
   "status": "superseded"
  },
  {
   "date": "2026-11-20",
   "source": "first-party reads 2026-11-20 (portfolio research); NexLife 2026-11-06, re-read unchanged 2026-11-20",
   "basis": "lowest all-in monthly figure per compounded program, membership included (annual fee / 12); standard-dose injectable; sale and prepaid figures included and flagged in \"basis\"; first-party reads 2026-11-20 except NexLife (prices as of 2026-11-06, re-read unchanged 2026-11-20); rows marked \"carried\" keep their 2026-10-15 figures",
   "tirzepatide": {
    "programs": 24,
    "low": 69,
    "high": 299,
    "median": 149
   },
   "semaglutide": {
    "programs": 23,
    "low": 39,
    "high": 249,
    "median": 99
   },
   "nexlife": {
    "tirzepatide": [
     129,
     125,
     119,
     115
    ],
    "semaglutide": [
     109,
     105,
     99,
     95
    ]
   }
  }
 ]
}